SS
FLNA

SBI Securities’s Filana Therapeutics FLNA Stock Holding History

SBI Securities’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.24K Buy
1,886
+655
+53% +$933 ﹤0.01% 2517
2026
Q1 		$2.08K Sell
1,231
-10
-0.8% -$21 ﹤0.01% 2411
2025
Q4 		$2.46K Sell
1,241
-208
-14% -$666 ﹤0.01% 2308
2025
Q3 		$4.22K Hold
1,449
– – ﹤0.01% 2117
2025
Q2 		$2.62K Buy
1,449
+202
+16% +$359 ﹤0.01% 2275
2025
Q1 		$1.87K Buy
1,247
+19
+2% +$48 ﹤0.01% 2317
2024
Q4 		$2.9K Buy
+1,228
New +$21.6K ﹤0.01% 2137

Other funds holding FLNA

AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
SWA
SOA Wealth Advisors New York $595M AUM 25.98% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SBI Securities's FLNA Position: Q2 2026 in Review

SBI Securities increased its Filana Therapeutics (FLNA) stake by 53% in Q2 2026, buying an estimated $933 and bringing the position to 1,886 shares worth $2.24K. The position accounts for ﹤0.01% of the portfolio, ranked #2517.

SBI Securities first reported a position in FLNA in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.22K in Q3 2025. 14 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • SBI Securities held 1,886 shares of Filana Therapeutics worth $2.24K as of Q2 2026.
  • SBI Securities bought 655 Filana Therapeutics shares in Q2 2026, an estimated $933.
  • Filana Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2517 holding.
  • SBI Securities first reported a position in Filana Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Filana Therapeutics position peaked at $4.22K in Q3 2025.
  • 14 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.